Ready for the frontline

Is early thoracoscope decortication the new standard of care for advanced pneumonia with empyema?

Adam M. Suchar, Amer H. Zureikat, Loretto Glynn, Mindy B. Statter, Jongin Lee, Donald C. Liu

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Video-assisted thoracoscopic decortication (VATD) has been established as an effective and potentially less morbid alternative to open thoracotomy for the management of empyema. However, the timing and role of VATD for advanced pneumonia with empyema is still controversial. In assessing surgical outcome, the authors reviewed their VATD experience in children with empyema or empyema with necrotizing pneumonia. The charts of 42 children who underwent VATD at our institution between July 2001 and July 2005 were retrospectively reviewed for surgical outcome. For purposes of analysis, patients were cohorted into four classes with increasing severity of pneumonia: 1 (-) intraoperative pleural fluid cultures, (-) necrotizing pneumonia, 18 (43%); 2 (+) pleural fluid cultures, (-) necrotizing pneumonia, 10 (24%); 3 (-) pleural fluid cultures, (+) necrotizing pneumonia, 6 (14%); 4 (+) pleural fluid cultures, (+) necrotizing pneumonia, 8 (19%). A P value of <0.05 via Student's t test or Fischer's exact analysis was considered an indicator of significant difference in the comparison of group outcomes. VATD was successfully completed in all 42 patients with no mortality and without significant morbidity (82% had less than 20 cc blood loss). There was found to be no significant difference (p = NS) in time to surgical discharge (removal of chest tube) among all groups. Hospital length of stay postsurgery was found to be significantly increased between 1 and 4 (6 days vs 9 days; P = 0.038). 14/14 (100%) of children with necrotizing pneumonia were found to have evidence of lung parenchymal preservation with improved aeration on follow-up CT scan and/or chest x-rays. The authors conclude that early VATD in children with advanced pneumonia with empyema is indicated to avoid unnecessarily lengthy hospitalization and prolonged intravenous antibiotic therapy. Furthermore, early VATD can be safely performed in various stages of advanced pneumonia with empyema, promoting lung salvage, and accelerating clinical recovery.

Original languageEnglish (US)
Pages (from-to)688-692
Number of pages5
JournalAmerican Surgeon
Volume72
Issue number8
StatePublished - Aug 2006
Externally publishedYes

Fingerprint

Thoracoscopes
Empyema
Standard of Care
Pneumonia
Length of Stay
Chest Tubes
Lung
Thoracotomy
Necrotizing Pneumonia
Hospitalization
Thorax
X-Rays
Students
Anti-Bacterial Agents
Morbidity
Mortality

ASJC Scopus subject areas

  • Surgery

Cite this

Ready for the frontline : Is early thoracoscope decortication the new standard of care for advanced pneumonia with empyema? / Suchar, Adam M.; Zureikat, Amer H.; Glynn, Loretto; Statter, Mindy B.; Lee, Jongin; Liu, Donald C.

In: American Surgeon, Vol. 72, No. 8, 08.2006, p. 688-692.

Research output: Contribution to journalArticle

Suchar, Adam M. ; Zureikat, Amer H. ; Glynn, Loretto ; Statter, Mindy B. ; Lee, Jongin ; Liu, Donald C. / Ready for the frontline : Is early thoracoscope decortication the new standard of care for advanced pneumonia with empyema?. In: American Surgeon. 2006 ; Vol. 72, No. 8. pp. 688-692.
@article{b0919fa329544f319c84c954220cc332,
title = "Ready for the frontline: Is early thoracoscope decortication the new standard of care for advanced pneumonia with empyema?",
abstract = "Video-assisted thoracoscopic decortication (VATD) has been established as an effective and potentially less morbid alternative to open thoracotomy for the management of empyema. However, the timing and role of VATD for advanced pneumonia with empyema is still controversial. In assessing surgical outcome, the authors reviewed their VATD experience in children with empyema or empyema with necrotizing pneumonia. The charts of 42 children who underwent VATD at our institution between July 2001 and July 2005 were retrospectively reviewed for surgical outcome. For purposes of analysis, patients were cohorted into four classes with increasing severity of pneumonia: 1 (-) intraoperative pleural fluid cultures, (-) necrotizing pneumonia, 18 (43{\%}); 2 (+) pleural fluid cultures, (-) necrotizing pneumonia, 10 (24{\%}); 3 (-) pleural fluid cultures, (+) necrotizing pneumonia, 6 (14{\%}); 4 (+) pleural fluid cultures, (+) necrotizing pneumonia, 8 (19{\%}). A P value of <0.05 via Student's t test or Fischer's exact analysis was considered an indicator of significant difference in the comparison of group outcomes. VATD was successfully completed in all 42 patients with no mortality and without significant morbidity (82{\%} had less than 20 cc blood loss). There was found to be no significant difference (p = NS) in time to surgical discharge (removal of chest tube) among all groups. Hospital length of stay postsurgery was found to be significantly increased between 1 and 4 (6 days vs 9 days; P = 0.038). 14/14 (100{\%}) of children with necrotizing pneumonia were found to have evidence of lung parenchymal preservation with improved aeration on follow-up CT scan and/or chest x-rays. The authors conclude that early VATD in children with advanced pneumonia with empyema is indicated to avoid unnecessarily lengthy hospitalization and prolonged intravenous antibiotic therapy. Furthermore, early VATD can be safely performed in various stages of advanced pneumonia with empyema, promoting lung salvage, and accelerating clinical recovery.",
author = "Suchar, {Adam M.} and Zureikat, {Amer H.} and Loretto Glynn and Statter, {Mindy B.} and Jongin Lee and Liu, {Donald C.}",
year = "2006",
month = "8",
language = "English (US)",
volume = "72",
pages = "688--692",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "8",

}

TY - JOUR

T1 - Ready for the frontline

T2 - Is early thoracoscope decortication the new standard of care for advanced pneumonia with empyema?

AU - Suchar, Adam M.

AU - Zureikat, Amer H.

AU - Glynn, Loretto

AU - Statter, Mindy B.

AU - Lee, Jongin

AU - Liu, Donald C.

PY - 2006/8

Y1 - 2006/8

N2 - Video-assisted thoracoscopic decortication (VATD) has been established as an effective and potentially less morbid alternative to open thoracotomy for the management of empyema. However, the timing and role of VATD for advanced pneumonia with empyema is still controversial. In assessing surgical outcome, the authors reviewed their VATD experience in children with empyema or empyema with necrotizing pneumonia. The charts of 42 children who underwent VATD at our institution between July 2001 and July 2005 were retrospectively reviewed for surgical outcome. For purposes of analysis, patients were cohorted into four classes with increasing severity of pneumonia: 1 (-) intraoperative pleural fluid cultures, (-) necrotizing pneumonia, 18 (43%); 2 (+) pleural fluid cultures, (-) necrotizing pneumonia, 10 (24%); 3 (-) pleural fluid cultures, (+) necrotizing pneumonia, 6 (14%); 4 (+) pleural fluid cultures, (+) necrotizing pneumonia, 8 (19%). A P value of <0.05 via Student's t test or Fischer's exact analysis was considered an indicator of significant difference in the comparison of group outcomes. VATD was successfully completed in all 42 patients with no mortality and without significant morbidity (82% had less than 20 cc blood loss). There was found to be no significant difference (p = NS) in time to surgical discharge (removal of chest tube) among all groups. Hospital length of stay postsurgery was found to be significantly increased between 1 and 4 (6 days vs 9 days; P = 0.038). 14/14 (100%) of children with necrotizing pneumonia were found to have evidence of lung parenchymal preservation with improved aeration on follow-up CT scan and/or chest x-rays. The authors conclude that early VATD in children with advanced pneumonia with empyema is indicated to avoid unnecessarily lengthy hospitalization and prolonged intravenous antibiotic therapy. Furthermore, early VATD can be safely performed in various stages of advanced pneumonia with empyema, promoting lung salvage, and accelerating clinical recovery.

AB - Video-assisted thoracoscopic decortication (VATD) has been established as an effective and potentially less morbid alternative to open thoracotomy for the management of empyema. However, the timing and role of VATD for advanced pneumonia with empyema is still controversial. In assessing surgical outcome, the authors reviewed their VATD experience in children with empyema or empyema with necrotizing pneumonia. The charts of 42 children who underwent VATD at our institution between July 2001 and July 2005 were retrospectively reviewed for surgical outcome. For purposes of analysis, patients were cohorted into four classes with increasing severity of pneumonia: 1 (-) intraoperative pleural fluid cultures, (-) necrotizing pneumonia, 18 (43%); 2 (+) pleural fluid cultures, (-) necrotizing pneumonia, 10 (24%); 3 (-) pleural fluid cultures, (+) necrotizing pneumonia, 6 (14%); 4 (+) pleural fluid cultures, (+) necrotizing pneumonia, 8 (19%). A P value of <0.05 via Student's t test or Fischer's exact analysis was considered an indicator of significant difference in the comparison of group outcomes. VATD was successfully completed in all 42 patients with no mortality and without significant morbidity (82% had less than 20 cc blood loss). There was found to be no significant difference (p = NS) in time to surgical discharge (removal of chest tube) among all groups. Hospital length of stay postsurgery was found to be significantly increased between 1 and 4 (6 days vs 9 days; P = 0.038). 14/14 (100%) of children with necrotizing pneumonia were found to have evidence of lung parenchymal preservation with improved aeration on follow-up CT scan and/or chest x-rays. The authors conclude that early VATD in children with advanced pneumonia with empyema is indicated to avoid unnecessarily lengthy hospitalization and prolonged intravenous antibiotic therapy. Furthermore, early VATD can be safely performed in various stages of advanced pneumonia with empyema, promoting lung salvage, and accelerating clinical recovery.

UR - http://www.scopus.com/inward/record.url?scp=33747854166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747854166&partnerID=8YFLogxK

M3 - Article

VL - 72

SP - 688

EP - 692

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 8

ER -